In a first in three years because the onset of the Covid-19 pandemic in March 2020, India reported lower than 100 instances on Monday. This comes at a time when infections are dropping repeatedly to contemporary lows every single day.

As per findings, no Covid associated deaths had been reported in the nation for 4 days at a stretch both, a first since March 2020.

Among the states, Kerala logged the best variety of instances throughout the previous week adopted by Karnataka which reported the second highest case rely at 214, as in comparison with 225 in the earlier week, adopted by Maharashtra with 124. Among states and UTs, Pondicherry was the one place that noticed a minor surge in instances.

India reported greater than 100 instances in a day on March 27 of 2020, and the every day tally hadn’t fallen to double digits since then, as per TOI’s Covid database. Cases have been steadily falling in India regardless of the huge wave in China, and consequent fears of a contemporary surge in the nation.

Notably, on January 16, the nationwide capital recorded no new Covid instances for the primary time since March 2020. Delhi recorded its first coronavirus case on March 2, 2020, and logged a whole of 20,07,313 instances with a cumulative positivity fee of 4.94 p.c and 26,522 pandemic-related fatalities to this point. Seven states, together with Maharashtra, Kerala, Karnataka, Andhra Pradesh, Tamil Nadu, Uttar Pradesh, and West Bengal, have recorded extra Covid instances than Delhi.

According to knowledge shared by the town well being division, the variety of energetic instances stood at simply 10. As many as 931 exams had been carried out the day prior to this, the well being division bulletin said. The metropolis reported only one new case on Sunday with a positivity fee of 0.05 p.c.

In the week spanning January 9-15, India recorded 1,062 Covid instances, which too was the bottom weekly tally since March 23-29, 2020.

Meanwhile, the Drug Controller General of India (DCGI) has permitted market authorization to Covid-19 vaccine Covovax. It can be used as a booster dose for adults who’ve been administered two doses of Covishield or Covaxin, sources mentioned. The DCGI’s approval got here following a suggestion by the topic knowledgeable committee of the Central Drugs Standard Control Organisation. Prakash Kumar Singh, director of presidency and regulatory affairs on the Serum Institute of India, had written to the DCGI for the approval of Covovax heterologous booster dose in view of the escalating Covid-19 pandemic scenario in some nations, an official supply mentioned.

Read all of the Latest India News right here